Ocular Therapeutix Sponsored Study Titled ‘Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration’ Posted To ClinicalTrials.Gov Site
https://clinicaltrials.gov/ct2/show/NCT04989699
Related Posts
Velodyne Shares Drop As Waymo Moves Out Of Lidar Selling Business
Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) owned self-driving company, Waymo, confirmed ending the sale of custom sensors to third parties after…
Lantronix Raises FY22 Sales Guidance From $112.5M-$127.5M To $125M-$129M vs $122.4M Estimate, Narrows Adj. EPS Guidance From $0.32-$0.40 To $0.31-$0.37 vs $0.34 Estimate
Lantronix Sees FY22 EPS $0.32-$0.40 Vs. $0.38 Est., Sales $112.5M-$127.5M Vs. $118.5M Est.
NI Collaborates With Austin Urban Technology Movement And Austin Community College To ‘Diversify the Local Tech Workforce’
NI Collaborates With Austin Urban Technology Movement and Austin Community College to Diversify the Local Tech Workforce
NI awards $400,000 to Austin Urban Technology Movement for workforce development